Dr. Chidinma Chima-Melton, MD

Dr. Chima-Melton practices at Community Hospital of Huntington Park in Huntington Park, California, part of Pipeline Health System.

Dr. Chima-Melton's NPI, 1306161625, was assigned on March 30, 2010. Dr. Chima-Melton graduated from Renaissance School of Medicine at Stony Brook University in 2010. Dr. Chima-Melton holds California license A125653.

Dr. Chima-Melton's primary practice is Community Hospital of Huntington Park, at 2623 E Slauson Ave, Huntington Park, CA 90255 in Los Angeles County. The practice phone is (323) 583-1931.

Dr. Chima-Melton's primary practice is Community Hospital of Huntington Park in Huntington Park, California, part of Pipeline Health System. Dr. Chima-Melton is also affiliated with Memorial Hospital of Gardena. The medical group on file is Tele-ICU.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chima-Melton practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Chima-Melton's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Chima-Melton is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Chima-Melton is licensed in California.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia, pulmonary fibrosis, pulmonary heart disease and sleep apnea among the conditions Dr. Chima-Melton treats.

CMS data shows 1,272 Medicare services from Dr. Chima-Melton across 3 procedure codes in 2024, for 275 Medicare patients. Medicare paid $175,900 for them.

CMS counts 275 Medicare patients who saw Dr. Chima-Melton in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have heart failure, and 75% have high blood pressure. 87% are also on Medicaid. Their average risk score is 3.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chima-Melton's median patient age at 63, with 40% women.

In 2024, Dr. Chima-Melton wrote 159 Medicare Part D claims for 50 patients. 41% of them were for generic drugs. CMS names the drug for 54 of them, across 4 drugs with 11 or more claims each, at $12,615 in total drug cost. In 2023, CMS named 269 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Chima-Melton for performance year 2024, reported as part of a group. Dr. Chima-Melton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chima-Melton as offering telehealth.

Dmand AI links 10 papers to Dr. Chima-Melton, published from 2015 to 2025. 2024 was the busiest year, with 3. The most frequent topics are COVID-19, COVID-19 Drug Treatment and Adenosine Monophosphate. Dr. Chima-Melton has published most often in Clin Infect Dis. Dr. Chima-Melton's most frequent co-authors are Robert Lawrence Gottlieb, MD, PhD, Andre C. Kalil, MD and Alpesh Navin Amin, MD.

CMS Open Payments shows 77 general payments to Dr. Chima-Melton from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 68% of the total. Gilead Sciences, Inc. paid the most, $31,606.

Dr. Chima-Melton graduated from Renaissance School of Medicine at Stony Brook University in 2010.

Dr. Chima-Melton is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.